Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

EPT Disclosure

9 Aug 2005 15:25

UBS AG (EPT)09 August 2005 This announcement replaces the previous RNS announcement reference 7900Preleased at 11:58 on 5 Aug 05. Amendment made to the BUY figures of BPB PLC dueto the late entry of a trade. All other information remains unchanged. FORM 38.5 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS (Rule 38.5 of The City Code on Takeovers and Mergers) Name of exempt principal trader UBS AG Company dealt in TOREX RETAIL PLC Relevant security dealt in ORDINARY SHARES 1P Name of offeree/offeror with whom connected TOREX RETAIL PLC Nature of connection # FINANCIAL ADVISER Date of dealing 03 August 2005 Total number of securities bought 2,590 Highest price paid (currency must be stated) 1.13 GBP Lowest price paid (currency must be stated) 1.13 GBP Total number of securities sold 0 Highest price paid (currency must be stated) 0 GBP Lowest price paid (currency must be stated) 0 GBP Date of disclosure 04 August 2005 Contact name ROBIN RAGNUTH Telephone number 020 7567 8289 # See the definition of "connected fund managers and principal traders" in theDefinitions Section of the Code. For details of the Code's dealing disclosure requirements, see Rules 8 and 38.5and their Notes which can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk. FORM 38.5 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS (Rule 38.5 of The City Code on Takeovers and Mergers) Name of exempt principal trader UBS AG Company dealt in BPB PLC Relevant security dealt in ORDINARY SHARES 50P Name of offeree/offeror with whom connected COMPAGNIE DE SAINT-GOBAIN Nature of connection # FINANCIAL ADVISER Date of dealing 03 August 2005 Total number of securities bought 17,198,046 Highest price paid (currency must be stated) 7.3950 GBP Lowest price paid (currency must be stated) 6.8550 GBP Total number of securities sold 18,806,741 Highest price paid (currency must be stated) 7.4000 GBP Lowest price paid (currency must be stated) 6.9200 GBP Date of disclosure 04 August 2005 Contact name ROBIN RAGNUTH Telephone number 020 7567 8289 # See the definition of "connected fund managers and principal traders" in theDefinitions Section of the Code. For details of the Code's dealing disclosure requirements, see Rules 8 and 38.5and their Notes which can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Feb 20251:46 pmRNSForm 8.3 - Tissue Regenix Group PLC
20th Feb 20259:00 amRNSForm 8.5 (EPT/NON-RI)
19th Feb 20259:26 amRNSForm 8.5 (EPT/NON-RI)
18th Feb 202510:07 amRNSForm 8.5- Tissue Regenix Group Plc
17th Feb 20259:38 amRNSForm 8.5 (EPT/NON-RI)
14th Feb 20252:16 pmRNSForm 8.3 - Tissue Regenix Group PLC
11th Feb 202511:11 amRNSForm 8.3 - Tissue Regenix Group PLC
5th Feb 202512:45 pmRNSForm 8.3 - Tissue Regenix Group PLC
4th Feb 202511:58 amRNSForm 8.3 - Tissue Regenix Group PLC
3rd Feb 202512:08 pmRNSForm 8.3 - Tissue Regenix Group PLC
31st Jan 20251:34 pmRNSForm 8.3 - Tissue Regenix Group PLC
31st Jan 20258:55 amRNSForm 8.5- Cavendish Securities PLC
30th Jan 20257:00 amRNSFull year trading update
24th Jan 202511:55 amRNSForm 8.3 - Tissue Regenix Group PLC
24th Jan 202510:31 amRNSForm 8.5 (EPT/NON-RI)
23rd Jan 20252:01 pmRNSForm 8.3 - Tissue Regenix Group PLC
15th Jan 20253:21 pmRNSForm 8.3 - Tissue Regenix Group plc
15th Jan 20251:25 pmRNSHolding(s) in Company
14th Jan 20252:02 pmRNSForm 8.3 - Tissue Regenix Group plc
14th Jan 20251:17 pmRNSForm 8.3 - Tissue Regenix Group PLC
13th Jan 20252:20 pmRNSHolding(s) in Company
13th Jan 20251:34 pmRNSForm 8.3 - Tissue Regenix Group PLC
9th Jan 20252:50 pmRNSForm 8.3 - Tissue Regenix Group PLC
8th Jan 20251:09 pmRNSForm 8.3 - Tissue Regenix Group PLC
8th Jan 20259:41 amRNSForm 8.5 (EPT/NON-RI)
7th Jan 202510:59 amRNSForm 8.5 (EPT/NON-RI)
3rd Jan 202511:23 amRNSForm 8.5 (EPT/NON-RI)
2nd Jan 202512:38 pmRNSForm 8.3 - Tissue Regenix Group PLC
16th Dec 20242:31 pmRNSForm 8.3 - Tissue Regenix Group PLC
16th Dec 20248:58 amRNSForm 8.5 (EPT/NON-RI) - Tissue Regenix Group PLC
13th Dec 202411:08 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 202410:19 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 202411:16 amRNSForm 8.5 (EPT/NON-RI)
10th Dec 202412:15 pmRNSForm 8.3 - Tissue Regenix Group PLC
9th Dec 20245:52 pmRNSForm 8.3 - Tissue Regenix Group plc
9th Dec 20242:44 pmRNSHolding(s) in Company
9th Dec 202411:35 amRNSForm 8.3 - Tissue Regenix Group PLC
6th Dec 20241:57 pmRNSForm 8.3 - Tissue Regenix Group plc
5th Dec 202412:04 pmRNSForm 8.3 - Tissue Regenix Group PLC
26th Nov 20247:00 amRNSExtended distribution agreement with Arthrex, Inc.
25th Nov 20249:30 amRNSForm 8.5 (EPT/NON-RI)
22nd Nov 20249:16 amRNSForm 8.5 (EPT/NON-RI)
21st Nov 20249:22 amRNSForm 8.5 (EPT/NON-RI)
20th Nov 20242:07 pmRNSHolding(s) in Company
20th Nov 202411:16 amRNSForm 8.5 (EPT/NON-RI)
20th Nov 202411:12 amRNSForm 8.3 - Tissue Regenix Group plc
19th Nov 20248:38 amRNSForm 8.5 (EPT/NON-RI)
18th Nov 202412:43 pmRNSForm 8.3 - Tissue Regenix Group PLC
15th Nov 20248:45 amRNSForm 8.3 - Tissue Regenix Group plc
14th Nov 20249:19 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.